Staff editor
William Fusco, gastroenterologist at Gemelli University Hospital in Rome, discusses the role of peppermint oil in the management of disorders of gut–brain interaction.
Maria Rescigno presents a preclinical study investigating a non-absorbable antibiotic with eubiotic properties in a mouse model of gastrointestinal toxicity induced by the chemotherapeutic agent 5-fluorouracil (5-FU).
According to Stephen Michael Collins, McMaster University, these vesicles may represent not only a new component of the microbiota–gut–brain axis, but also a promising platform for future targeted drug, vaccine…
The work of Angela Sessitsch, Head of Center at Austrian Institute of Technology, shows that environmental pressures such as drought can substantially reshape the plant microbiome.
David Suissa, CEO of BYOME LABS, discusses the growing interest in microbiome research, from the gut and vaginal ecosystems to the less explored skin, scalp and oral microbiomes.
Julie Rodriguez, researcher at Inserm (National Institute of Health and Medical Research, France) explored the main categories of microbiome-based biomarkers and their potential applications in clinical practice.
Marta Ciechonska of Salient Bioscience presented the company’s approach to developing standardized, reproducible microbiome tests based on shotgun metagenomic sequencing.
Gut microbiota, immunity and diet: twenty years of research and the future of personalized nutrition
Francisco Guarner, from Centro Médico Teknon in Barcelona (Spain), discussed the most recent researches in the field of microbiome and nutrition.
To better define the role of biotics in infant formula, future studies should be specifically designed to assess infection prevention, with adequate sample sizes, harmonised formulations and long-term follow-up.
Industry
Sponsored by
New study adds further strength to the evidence behind Bimuno GOS’ ‘performance powered by gut health’ approach.
